How can lawyers resolve patent disputes in biotech using emerging litigation strategies?
Biotech patent disputes can often be resolved through early validity and infringement analysis, targeted PTAB challenges, and strategic settlement—frequently reducing time and cost compared with full trial. As biologics, diagnostics, and gene-editing patents become more complex, parties increasingly use coordinated forum selection, expert-driven claim construction, and narrowed damages theories to improve outcomes. This article explains […]
How can lawyers resolve patent disputes in biotech using emerging litigation strategies? Read More »